Picture of IRLAB Therapeutics AB logo

IRLAB A — IRLAB Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Irlab: Clinical Drug Candidate Mesdopetam Published In JPET

May 6 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * IRLAB'S CLINICAL DRUG CANDIDATE MESDOPETAM PUBLISHED IN
JPET
    * PAPER REPORTING PRECLINICAL PHARMACOLOGY OF MESDOPETAM IS
NOW
PUBLISHED IN JPET
    * ADDITIONAL PAPER IS ALSO PUBLISHED IN JPET, INDICATING
THAT
MESDOPETAM COULD HAVE BENEFICIAL EFFECTS ON NEUROTROPHIC FACTORS

Source text for Eikon:  ID:nWkr39nFn2 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on IRLAB Therapeutics AB

See all news